Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/27/2001 | CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same |
06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
06/27/2001 | CN1300852A DNA sequence for coding human lysozyme gene and its application |
06/27/2001 | CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen |
06/27/2001 | CN1067550C Calcium receptor active molecules |
06/26/2001 | US6252139 Generating genetically engineered plants; incubate cells with nucleotide sequence coding cyclin protein, transform cells, propagate cells, isolate plants with amplified root propagation |
06/26/2001 | US6252138 Nucleotide sequences coding nematocide; for the production of disease resistant plants |
06/26/2001 | US6252136 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
06/26/2001 | US6252134 Generating plant with amplified baked goods qualities; transform wheat cell, propagate cell, recover wheat plants |
06/26/2001 | US6252133 Regenerating embryo of mammal; transfer nucleus of diploid cell into oocyte, activate and develop embryo |
06/26/2001 | US6252130 Production of somatic mosaicism in mammals using a recombinatorial substrate |
06/26/2001 | US6252051 ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor |
06/26/2001 | US6252050 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
06/26/2001 | US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth |
06/26/2001 | US6251859 Deepithelialized skin diffusion cell system |
06/26/2001 | US6251672 Culturing mammalian cells in contact with cell surface proteins |
06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
06/26/2001 | US6251670 Method of culturing cells in suspension using lectins |
06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
06/26/2001 | US6251665 Producing cancer-specific cells by isolating cd34 positive hematopoietic stem cells, incubating in cell culture medium, mixing with tumor cell material, and incubating with tumor necrosis factor-alpha |
06/26/2001 | US6251645 Leflunomide-resistant helicase; anticarcinogenic agents; antidiabetic agents; immunosuppressants; treatment of alzheimer's disease, atherosclerosis, osteoporosis, autoimmune disorders, and rheumatoid arthritis |
06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
06/26/2001 | US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity |
06/26/2001 | US6251612 Hybridoma; cheap and sensitive monitoring of water pollution |
06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
06/26/2001 | US6251590 Differential Qualitative screening |
06/26/2001 | US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments |
06/26/2001 | US6251398 Fusion proteins comprising transport proteins comprising sequences from herpesviral vp22 or fragments thereof together with an antigenic sequence greater than 12 amino acids in length |
06/26/2001 | US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids |
06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
06/26/2001 | US6251383 Method for ex-vivo expansion of hematopoietic cells |
06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
06/26/2001 | CA1341263C Recombinant fowlpox virus, heterologous protein expression vectors, and fowl vaccines derived from this virus |
06/21/2001 | WO2001044816A2 Conformational and topological protein regulation |
06/21/2001 | WO2001044514A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
06/21/2001 | WO2001044497A2 Protein kinase regulation |
06/21/2001 | WO2001044483A1 Transgenic insect |
06/21/2001 | WO2001044482A2 Optimized t-dna transfer and vectors therefor |
06/21/2001 | WO2001044481A1 Fusion protein delivery system and uses thereof |
06/21/2001 | WO2001044480A2 Enzymes and genes used for producing vanillin |
06/21/2001 | WO2001044478A2 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
06/21/2001 | WO2001044463A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
06/21/2001 | WO2001044459A2 Method to enhance agrobacterium-mediated transformation of plants |
06/21/2001 | WO2001044458A2 Bovine immunodeficiency virus (biv) based vectors |
06/21/2001 | WO2001044454A2 Root-specific promoter |
06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
06/21/2001 | WO2001044447A1 Compositions and methods for halogenation reactions |
06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
06/21/2001 | WO2001044442A1 Arginine-enriched medium composition used for mass-producing recombinant protein in animal cell culture |
06/21/2001 | WO2001044441A1 Stabilizing diluent for polypeptides and antigens |
06/21/2001 | WO2001044438A2 Serological diagnostic method with rickettsia pulicis bacterium |
06/21/2001 | WO2001044300A2 Brain specific binding members |
06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
06/21/2001 | WO2001044286A2 Five-helix protein |
06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
06/21/2001 | WO2001044280A2 Methods and compositions for the manufacture of replication incompetent adenovirus |
06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
06/21/2001 | WO2001043869A2 Cell arrays and the uses thereof |
06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
06/21/2001 | WO2001043694A2 Compositions and methods for caspase-induced apoptosis |
06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
06/21/2001 | WO2001043539A1 Animals with insufficient expression of uridine phosphorylase |
06/21/2001 | WO2001019871A3 Delivery system for antidandruff agent |
06/21/2001 | WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
06/21/2001 | WO2001011051A3 Chimeric proteins |
06/21/2001 | WO2001011034A3 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
06/21/2001 | WO2001007607A8 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
06/21/2001 | WO2001000795A9 A method for producing cloned cows |
06/21/2001 | WO2000079002A8 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof |
06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
06/21/2001 | WO2000075278B1 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
06/21/2001 | WO2000058472A8 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
06/21/2001 | WO2000055345A9 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
06/21/2001 | WO2000020574A9 Fusions of scaffold proteins with random peptide libraries |
06/21/2001 | WO2000014212A9 Novel protein kinase molecules and uses therefor |
06/21/2001 | WO1999057246A9 Animal cell culture media comprising non-animal or plant-derived nutrients |
06/21/2001 | WO1998011243A9 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
06/21/2001 | DE19961519A1 New nucleic acid encoding plant receptor-like protein kinase, useful for identifying new herbicides and growth regulators |
06/21/2001 | DE19960106A1 Enzyme und Gene für die Herstellung von Vanillin Enzymes and genes for the production of vanillin |
06/21/2001 | DE19957470A1 Tetrahydropyrimidin-Dioxygenase-Gen sowie Verfahren zur enzymatischen in vivo und in vitro Produktion von hydroxylierten Tetrahydropyrimidinen Tetrahydropyrimidine dioxygenase gene as well as methods for the enzymatic in vivo and in vitro production of hydroxylated tetrahydropyrimidines |
06/21/2001 | DE19956513A1 Resolvase-katalysierte, Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Resolvase-catalyzed sequence-specific DNA recombination in eukaryotic cells |
06/21/2001 | DE19956503A1 Spritzbares Knochenersatzmaterial An injectable bone substitute material |
06/21/2001 | CA2641218A1 Hybrid promoter for use in plants |
06/21/2001 | CA2640686A1 Novel plant expression constructs |
06/21/2001 | CA2396654A1 Core 1 .beta.3-galactosyl transferases and methods of use thereof |
06/21/2001 | CA2396539A1 Root-specific promoter |
06/21/2001 | CA2396503A1 Stabilizing diluent for polypeptides and antigens |
06/21/2001 | CA2394840A1 Optimized t-dna transfer and vectors therefor |
06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
06/21/2001 | CA2394367A1 Method to enhance agrobacterium-mediated transformation of plants |
06/21/2001 | CA2394269A1 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
06/21/2001 | CA2394149A1 Serological diagnostic method with rickettsia pulicis bacterium |